エリミネーション・アディション・メカニズムによるタンパク質S-グリコ変異
Journal of the American Chemical Society
|April 28, 2020
まとめ
研究者達は新しい反応を発見しました S-グリコ変異と呼ばれるもので 糖類がタンパク質に結合します この発見により,細胞内の代謝性グリカンラベル (MGL) の洗練された方法が生まれました.
科学分野:
- 化学生物学
- グライコバイオロジー
- 有機化学
背景:
- Per-O-アセチル化非自然なモノサッカライドは,代謝性グリカン (MGL) のラベル付けに不可欠である.
- 最近発見された非特異な反応は"S-グリコシレーション"と呼ばれ,これらの糖とタンパク質システインの間に発生します.
- このS-グリコシル化反応の背後にあるメカニズムは,ほとんど不明のままである.
研究 の 目的:
- S-グリコ変異の詳細な反応機構を解明する.
- 糖とタンパク質システインの間の人工S-グリコシレーションの形成を理解する.
- より効果的なMGLのために,改良された非自然なモノサッカライドを開発する.
主な方法:
- S-グリコ変異反応のメカニズム的調査
- 塩基誘導反応の分析
- 反応の中間物質と産物の識別
主要な成果:
- S-グリコシレーションは,S-グリコ変異と呼ばれる非典型のグリコシレーションである.
- パー-O-アセチル化モノサッカリドは,α,β-不飽和アルデヒドを形成するために,塩基誘導によるβ除去を経験する.
- これらのアルデヒドは,ミカエル添加によってシステイン残留物と反応し,半酸性形の3チオラ酸糖を生成する.
結論:
- S-グリコ変異のメカニズムは,典型的なグリコシル化ではなく,除去添加を含みます.
- この理解により,改良された非自然なモノサッカライドの開発が可能になる.
- 1,6-di-O-propionyl-N-azidoacetylgalactosamine (1,6-Pr2GalNAz) は強化されたMGL反応剤として提案されている.
関連する概念動画
Protein Glycosylation
9.0K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
9.0K
Oligosaccharide Assembly
3.4K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.4K
Protein Modifications in the RER
6.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
6.6K
Proteoglycans
4.5K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.5K
Covalently Linked Protein Regulators
8.5K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.5K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
790
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
790


